Profile data is unavailable for this security.
About the company
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells (MLASCs), T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It also develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance and Interfyl products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).
- Revenue in USD (TTM)22.77m
- Net income in USD-196.30m
- Incorporated2018
- Employees120.00
- LocationCelularity Inc170 Park AveFLORHAM PARK 07932United StatesUSA
- Phone+1 (908) 768-2170
- Fax+1 (302) 636-5454
- Websitehttps://celularity.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals Inc | 81.00k | -42.62m | 51.72m | 49.00 | -- | 1.16 | -- | 638.47 | -1.52 | -1.52 | 0.0029 | 1.43 | 0.0009 | -- | -- | 1,653.06 | -45.12 | -46.98 | -50.13 | -52.71 | -- | -- | -52,620.99 | -6,683.95 | -- | -- | 0.0006 | -- | -92.14 | -- | -47.86 | -- | 9.75 | -- |
Syros Pharmaceuticals Inc | 4.15m | -131.56m | 52.01m | 68.00 | -- | -- | -- | 12.54 | -4.30 | -4.30 | 0.1222 | -0.2369 | 0.0288 | -- | -- | 61,000.00 | -91.46 | -54.44 | -112.06 | -64.32 | -- | -- | -3,171.70 | -772.82 | -- | -- | 1.18 | -- | -33.23 | 37.12 | -73.87 | -- | -27.78 | -- |
Intensity Therapeutics Inc | 0.00 | -15.08m | 52.21m | 5.00 | -- | 9.73 | -- | -- | -1.10 | -1.10 | 0.00 | 0.3898 | 0.00 | -- | -- | 0.00 | -112.08 | -- | -146.09 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.45 | -- | -- | -- |
Shattuck Labs Inc | 4.12m | -85.28m | 53.93m | 75.00 | -- | 0.4876 | -- | 13.08 | -1.85 | -1.85 | 0.0883 | 2.32 | 0.029 | -- | -- | 54,986.67 | -60.08 | -29.14 | -66.66 | -32.42 | -- | -- | -2,067.99 | -565.33 | -- | -- | 0.00 | -- | 154.14 | -40.62 | 14.37 | -- | -19.15 | -- |
Gain Therapeutics Inc | 0.00 | -21.60m | 54.52m | 29.00 | -- | 4.56 | -- | -- | -1.33 | -1.33 | 0.00 | 0.4682 | 0.00 | -- | -- | 0.00 | -115.33 | -- | -170.44 | -- | -- | -- | -- | -13,827.07 | -- | -- | 0.0396 | -- | -60.62 | 21.77 | -26.59 | -- | 13.96 | -- |
Tevogen Bio Holdings Inc | 0.00 | 57.92m | 54.52m | 17.00 | 0.8501 | -- | -- | -- | 0.3758 | 0.3758 | 0.00 | -0.0452 | 0.00 | -- | -- | 0.00 | 1,217.57 | -- | -- | -- | -- | -- | -- | -- | -- | -702.58 | -- | -- | -- | -- | 99.69 | -- | -- | -- |
Celularity Inc | 22.77m | -196.30m | 54.96m | 120.00 | -- | 1.18 | -- | 2.41 | -11.29 | -11.29 | 1.30 | 2.11 | 0.0836 | 2.90 | 2.39 | 189,758.30 | -72.04 | -19.19 | -94.47 | -20.99 | 29.66 | -- | -862.04 | -454.79 | 0.2086 | 1.37 | 0.4893 | -- | 26.68 | -- | -1,483.14 | -- | -- | -- |
enVVeno Medical Corp | 0.00 | -20.60m | 56.12m | 31.00 | -- | 1.11 | -- | -- | -1.43 | -1.43 | 0.00 | 2.88 | 0.00 | -- | -- | 0.00 | -56.37 | -58.43 | -59.43 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
Prenetics Global Ltd | 22.25m | -49.97m | 56.20m | 320.00 | -- | 0.2453 | -- | 2.53 | -4.33 | -5.32 | 1.91 | 18.75 | 0.0832 | 3.89 | 4.53 | 69,535.41 | -19.43 | -- | -23.55 | -- | 45.56 | -- | -233.41 | -- | 2.25 | -5.17 | 0.0086 | -- | 65.17 | -- | 75.91 | -- | -- | -- |
Kezar Life Sciences Inc | 7.00m | -98.57m | 56.47m | 58.00 | -- | 0.3744 | -- | 8.07 | -1.35 | -1.35 | 0.0962 | 2.07 | 0.0316 | -- | -- | 120,689.70 | -44.47 | -32.54 | -47.84 | -34.09 | -- | -- | -1,408.11 | -4,308.11 | -- | -- | 0.0634 | -- | -- | -- | -49.28 | -- | 10.08 | -- |
Regencell Bioscience Holdings Ltd | 0.00 | -4.71m | 57.26m | 12.00 | -- | 5.63 | -- | -- | -0.362 | -0.362 | 0.00 | 0.781 | 0.00 | -- | -- | 0.00 | -37.91 | -- | -37.91 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 21.15 | -- | -- | -- |
Mural Oncology PLC | 0.00 | -173.30m | 58.10m | 117.00 | -- | 0.2822 | -- | -- | -10.35 | -10.35 | 0.00 | 12.09 | 0.00 | -- | -- | 0.00 | -131.01 | -- | -164.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
Enzo Biochem Inc | 33.34m | -17.55m | 58.15m | 179.00 | -- | 0.8386 | -- | 1.74 | -0.3516 | 0.9194 | 0.6633 | 1.35 | 0.4028 | 1.66 | 4.91 | 186,257.00 | -21.20 | -12.21 | -34.50 | -15.79 | 43.66 | 37.09 | -52.63 | -18.76 | 3.16 | -- | 0.053 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
Omega Therapeutics Inc | 6.31m | -78.90m | 59.02m | 93.00 | -- | 2.25 | -- | 9.35 | -1.43 | -1.43 | 0.1145 | 0.4762 | 0.0318 | -- | 6.67 | 67,892.48 | -39.72 | -- | -46.68 | -- | -- | -- | -1,249.54 | -- | -- | -- | 0.3917 | -- | 49.25 | -- | 5.13 | -- | -- | -- |
Aeon Biopharma Inc | 0.00 | -305.52m | 59.28m | 5.00 | -- | -- | -- | -- | -8.40 | -8.40 | 0.00 | -0.7144 | 0.00 | -- | -- | 0.00 | -6,646.10 | -- | -- | -- | -- | -- | -- | -- | -- | 9.21 | -- | -- | -- | -- | -631.85 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Starr Investment Holdings LLCas of 30 Apr 2024 | 1.53m | 7.02% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 382.60k | 1.76% |
Geode Capital Management LLCas of 30 Jun 2024 | 141.56k | 0.65% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 76.36k | 0.35% |
Cresset Asset Management LLCas of 31 Mar 2024 | 35.00k | 0.16% |
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 27.35k | 0.13% |
Renaissance Technologies LLCas of 30 Jun 2024 | 25.50k | 0.12% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 24.93k | 0.11% |
HB Wealth Management LLC (GA)as of 30 Jun 2024 | 24.00k | 0.11% |
City National Rochdale LLCas of 31 Mar 2024 | 22.50k | 0.10% |